📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
11
GLSI Latest News & AI Sentiment Analysis
1 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Greenwich LifeSciences Stock Gains 4% After Extending Share Lock-Up
GLSI shares rallied 4.5% following a board announcement to extend the lock-up period for insiders and pre-IPO investors through January...
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
Greenwich LifeSciences (GLSI) has secured regulatory clearance to expand its Phase III FLAMINGO-01 trial into the United Kingdom,...
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
GLSI announced routine clinical updates on FLAMINGO-01, its Phase III trial evaluating GLSI-100, an immunotherapy candidate for breast...
Greenwich LifeSciences The Overlooked Need (NASDAQ:GLSI)
GLSI represents a concentrated single-asset biotech thesis centered on GLSI-100, a clinical-stage immunotherapy targeting HER2-positive...
Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
Greenwich LifeSciences (GLSI) achieved a significant regulatory milestone with European approval for commercially manufactured GP2 in...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice